Clinical Trial Update: An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SABER®-Bupivacaine for postoperative pain control after arthroscopic shoulder surgery; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthroscopic Shoulder Surgery-related Pain
• Postoperative Pain

Drugs mentioned

• SABER®-Bupivacaine (bupivacaine)

Snippet

Sponsor: Durect | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-06-09